scholarly journals Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial

2014 ◽  
Vol 2 (9) ◽  
pp. 710-718 ◽  
Author(s):  
Kurt J Griffin ◽  
Paul A Thompson ◽  
Michael Gottschalk ◽  
Jennifer H Kyllo ◽  
Alex Rabinovitch
Keyword(s):  
Type 1 Diabetes ◽  
Combination Therapy ◽  
Phase 2 ◽  
Recent Onset ◽  
Onset Type ◽  
Phase 2 Trial

scholarly journals Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

2021 ◽  
Author(s):  
Stephen E Gitelman ◽  
Brian N Bundy ◽  
Ele Ferrannini ◽  
Noha Lim ◽  
J Lori Blanchfield ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Imatinib Therapy ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Recent Onset ◽  
Onset Type ◽  
Phase 2 Trial

Imatinib Therapy for Patients with Recent-Onset Type 1 Diabetes: A Randomised Blinded Phase 2 Trial

2021 ◽  
Author(s):  
Stephen E. Gitelman ◽  
Brian N. Bundy ◽  
Ele Ferrannini ◽  
Noha Lim ◽  
J. Lori Blanchfield ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Imatinib Therapy ◽  
Phase 2 ◽  
Recent Onset ◽  
Onset Type ◽  
Phase 2 Trial

scholarly journals Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

2013 ◽  
Vol 1 (4) ◽  
pp. 306-316 ◽  
Author(s):  
Stephen E Gitelman ◽  
Peter A Gottlieb ◽  
Mark R Rigby ◽  
Eric I Felner ◽  
Steven M Willi ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Antithymocyte Globulin ◽  
Phase 2 ◽  
Recent Onset ◽  
Onset Type ◽  
Phase 2 Trial

Combination therapy in recent-onset type 1 diabetes

2021 ◽  
Vol 9 (4) ◽  
pp. 191-193
Author(s):  
S Alice Long ◽  
Cate Speake
Keyword(s):  
Type 1 Diabetes ◽  
Combination Therapy ◽  
Recent Onset ◽  
Onset Type

scholarly journals Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

2013 ◽  
Vol 1 (4) ◽  
pp. 284-294 ◽  
Author(s):  
Mark R Rigby ◽  
Linda A DiMeglio ◽  
Marc S Rendell ◽  
Eric I Felner ◽  
Jean M Dostou ◽  
...  
Keyword(s):  
T Cells ◽  
Type 1 Diabetes ◽  
Memory T Cells ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Onset Type ◽  
Phase 2 Trial ◽  
New Onset

249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 249-OR
Author(s):  
EMANUELE BOSI ◽  
PAOLO POZZILLI ◽  
FRANCESCO GIORGINO ◽  
EFISIO COSSU ◽  
THOMAS LINN ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Adult Patients ◽  
Phase 2 ◽  
Double Blind ◽  
Onset Type ◽  
Phase 2 Trial ◽  
New Onset

Early parallel progression of peripheral and cardiac autonomic nerve dysfunction in recent-onset type 1 diabetes patients

2019 ◽  
Author(s):  
GJ Bönhof ◽  
A Strom ◽  
K Müssig ◽  
OP Zaharia ◽  
J Szendrödi ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Autonomic Nerve ◽  
Recent Onset ◽  
Onset Type ◽  
Nerve Dysfunction ◽  
Diabetes Patients

Alpha-1 Antitrypsin Therapy in Recent-Onset Type 1 Diabetes

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 235-OR
Author(s):  
YAEL LEBENTHAL ◽  
AVIVIT BRENER ◽  
ELI HERSHKOVITZ ◽  
NAIM SHEHADEH ◽  
SHLOMIT SHALITIN ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Recent Onset ◽  
Onset Type ◽  
Alpha 1 Antitrypsin
Sign in / Sign up

Export Citation Format

Share Document